Demonstration of polymer-grafted WS2 reinforcing materials in polyester matrices, highlighting implications for enhanced stability.
Layered transition metal dichalcogenides (TMDs) are widely regarded as chemically inert nanofillers in polymer composites. Here, we demonstrate that this assumption fails under melt-processing conditions. We show that pristine WS2 nanopowders act as heterogeneous catalysts for polyester chain scission during melt extrusion, inducing a catastrophic, 10-fold reduction in molecular weight, severe loss of melt viscosity, printing failure, and brittle mechanical behavior at filler loadings as low as 0.2 wt %. To suppress this unexpected catalytic activity, we develop an edge- and defect-selective functionalization strategy for WS2 based on covalent carboxylation and hydroxylation, followed by surface-initiated ring-opening polymerization of ε-caprolactone. Spectroscopic and microscopic analyses (XPS, XRD, HAADF-STEM, and EELS) demonstrate that polymer grafting is confined to edge and defect sites, while preserving the multilayer 2H-WS2 lattice. When incorporated into a polycaprolactone (PCL) matrix and processed by large-format fused granular fabrication, polymer-grafted WS2 nanostructures exhibit stable melt rheology, excellent printability, and substantial mechanical reinforcement, with Young’s modulus and tensile strength increases up to 45% and 65%, respectively, without loss of ductility. Crucially, polymer grafting effectively passivates catalytically active WS2 edge and defect sites, preventing melt-induced polymer degradation. These findings provide direct experimental evidence that exposed edge sites in layered nanomaterials can actively catalyze polymer degradation under melt-processing conditions and establish edge-site passivation as a general design principle to mitigate chemically driven polymer degradation in polyester-based systems during melt processing, with the magnitude of the effect depending on the chemical susceptibility of the host polymer.
No takes yet. Share an insight, caveat, or question.
Maturi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: